Head-to-head dispatch
Amble vs HealthRX
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Telehealth weight loss provider offering compounded semaglutide and tiered tirzepatide programs.
$179/mo (starting dose, compounded) sema · $289/mo (starting dose, compounded) tirz · Verified July 20, 2026
Marked down on: Limited public information on program details
Desk Score
A LegitScript-certified compounding platform whose pricing page prints every plan's total, per-month rate and renewal price — and whose renewals are cheaper than sign-up.
$190/mo month-to-month ($149 first month on Subscribe & Save, renews at $165) · $99/mo on a 12-month prepay ($1,188) sema · $239/mo month-to-month ($193 first month on Subscribe & Save, renews at $214) · $179/mo on a 12-month prepay ($2,148) tirz · Verified August 29, 2026
Marked down on: Compounded medications are not FDA-approved
HealthRX takes this head-to-head with the higher Desk Score, 86/100 (B) against 76/100 (C) for Amble. Amble still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Amble
76/100
C
HealthRX
86/100
B
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Amble | HealthRX |
|---|---|---|
| Semaglutide | $179/mo (starting dose, compounded) | $190/mo month-to-month ($149 first month on Subscribe & Save, renews at $165) · $99/mo on a 12-month prepay ($1,188) |
| Tirzepatide | $289/mo (starting dose, compounded) | $239/mo month-to-month ($193 first month on Subscribe & Save, renews at $214) · $179/mo on a 12-month prepay ($2,148) |
| Coverage | All 50 states | All 50 states |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | Mainstream telehealth GLP-1 access. | Patients who want a certified program with every plan price and renewal in one table, and a full refund if a provider does not approve them. |
| Desk Score | 76/100C | 86/100B |
The verdict
Desk pick — HealthRXHealthRX takes this head-to-head with the higher Desk Score, 86/100 (B) against 76/100 (C) for Amble. Amble still holds its ground where its strengths line up with yours.
Choose Amble if…
Mainstream telehealth GLP-1 access.
$179/mo (starting dose, compounded) sema · $289/mo (starting dose, compounded) tirz · All 50 states
Choose HealthRX if…
Patients who want a certified program with every plan price and renewal in one table, and a full refund if a provider does not approve them.
$190/mo month-to-month ($149 first month on Subscribe & Save, renews at $165) · $99/mo on a 12-month prepay ($1,188) sema · $239/mo month-to-month ($193 first month on Subscribe & Save, renews at $214) · $179/mo on a 12-month prepay ($2,148) tirz · All 50 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Amble · HealthRX.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: one price at every dose, both molecules, all 50 states — but the $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- Amble vs CoreAge Rx
- CoreAge Rx vs HealthRX
- Amble vs Ondra Health
- HealthRX vs Trimi
- Amble vs Trimi
- Elara Health and Wellness vs HealthRX
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.